NextCure Announces Acceptance of IND Application for LNCB74
LNCB74 is a B7-H4-targeting antibody-drug conjugate being developed for multiple cancers in…
interop.io Announces Free Partner Edition, Paving the Way for Universal Application Interoperability
LONDON, Nov. 14, 2024 /PRNewswire/ -- interop.io, the global leader in desktop…
